Michigan Lawmakers Propose Psilocybin as Alternative PTSD Treatment

Michigan's legislative landscape is witnessing a significant shift as lawmakers introduce House Bill 4686, proposing the decriminalization of psilocybin for adults diagnosed with post-traumatic stress disorder (PTSD).

State Representative Mike McFall (D-Hazel Park) spearheaded the bill, emphasizing the evolving understanding of PTSD treatments and the potential benefits of psychedelics.

"Our understanding of medicine is constantly evolving, and there has been a shift in treating PTSD with psychedelics over the last decade," McFall stated during a press conference on June 25, 2025.

Preliminary research suggests that psilocybin can have life-changing effects for extended periods after treatment.

House Bill 4686 outlines specific criteria for individuals to legally possess psilocybin:

1. The individual must be 18 years or older.

2. They must have a medical record confirming a PTSD diagnosis.

3. Possession is limited to no more than two ounces of a substance containing psilocybin.

Michael G. Smith Jr., a retired U.S. Army Sergeant First Class, shared his personal experience, noting that microdosing psilocybin has been more effective in mitigating his PTSD symptoms than traditional therapies offered by the VA Health Care system.

He highlighted the potential of psilocybin to prevent life-threatening conditions associated with untreated PTSD, such as coronary vascular diseases and atrial fibrillation.

Michigan has been at the forefront of psychedelic decriminalization at the municipal level.

Cities like Ann Arbor, Detroit, Hazel Park, and Ferndale have already decriminalized psychedelics, setting a precedent for statewide legislation.

As House Bill 4686 progresses through the legislative process, it reflects a growing recognition of alternative treatments for mental health conditions and a commitment to supporting those affected by PTSD.

FAQ

What is House Bill 4686?

House Bill 4686 is proposed legislation in Michigan aiming to decriminalize the possession of psilocybin for adults diagnosed with PTSD.

Who is eligible under this bill?

Individuals aged 18 and older with a medical record confirming a PTSD diagnosis would be eligible to possess up to two ounces of psilocybin for personal use.

Why is psilocybin being considered for PTSD treatment?

Preliminary research indicates that psilocybin may have significant, long-lasting positive effects on PTSD symptoms, offering an alternative to traditional treatments.